Showing results (21-30 of 116) with videos related to
Sort By:
Pageof 12
Clinics in Liver Disease|November 24, 2015
Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisLaura Jopson, Jessica K Dyson, David E J JonesHepatology Communications|June 9, 2018
Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitisMarco Carbone, Maren H Harms, Willem J Lammers, et al.Digestive Diseases (Basel, Switzerland)|March 2, 2017
Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing CholangitisVinod S Hegade, David E J Jones, Gideon M HirschfieldDigestive Diseases (Basel, Switzerland)|May 4, 2017
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?Lin Lee Wong, Vinod S Hegade, David E J JonesJournal of Hepatology|February 21, 2006
Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measureJulia L Newton, Nij Bhala, Jennifer Burt, et al.Clinical Medicine (London, England)|September 26, 2015
Drug treatment of pruritus in liver diseasesVinod S Hegade, Stuart F W Kendrick, David E J JonesLiver International : Official Journal of the International Association for the Study of the Liver|January 9, 2013
Restless leg syndrome is a treatable cause of sleep disturbance and fatigue in primary biliary cirrhosisKirstie Anderson, David E J Jones, Katharine Wilton, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2006
Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosisJulia L Newton, John Allen, Simon Kerr, et al.Hepatology (Baltimore, Md.)|July 31, 2015
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitisMarco Carbone, Stephen J Sharp, Steve Flack, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2006
PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosisAnna McHugh, Amanda J Robe, Jeremy M Palmer, et al.Pageof 12